Anya Biotech wins the Proefdiervrij Venture Challenge 2022
June 28, 2022Anya Biotech, representing Amsterdam UMC, has won the second edition of the Proefdiervrij Venture Challenge on the 22nd of April 2022. Their winning innovation is based on research from the Department of Medical Biology at the AMC. The team takes home €25.000, – in prize money to kick-start their venture based on human heart models to treat cardiac disease.
The Anya Biotech team, consisting of Harsha Devalla, Marc Roelofs and Sander van Leeuwe, participated in the second edition of the Proefdiervrij Venture Challenge. In this bootcamp program,
the participating teams have been guided in the process of translating their scientific breakthrough into a solid business case. This specific version of the Venture Challenge was organised by Proefdiervrij, a foundation idealizing a future without animal testing. The participating teams have brought forward innovations contributing to this cause. In the final, the teams presented in front of an expert jury consisting of Geert-Jan Mulder, Rianne Ellenbroek, Giel Hendriks, Jos Joore and Susan Janssen. The final presentations and subsequent award ceremony took place at Pathé Buitenhof in Den Haag.
The vision of Anya Biotech is to dramatically improve the quality of life of patients suffering from cardiac arrhythmias. They will develop therapies for cardiac arrhythmias such as Atrial Fibrillation and Pacemaker Dysfunction. The cardiac models of Anya Biotech are based on human stem cells, and they mimic the human heart more accurately than the models that are currently used for drug discovery (e.g. animal models). This significantly improves their chances of identifying effective drugs for cardiac arrhythmias, which are currently not effectively treatable.
From Amsterdam UMC also inSteps (location AMC) and Simplexable (location VUmc) participated in the Proefdiervrij Venture Challenge 2022.
Photo credits: Proefdiervrij
More news
Contribute to Amsterdam’s Future: test your innovation at SAIL and the Amsterdam Marathon
Are you looking for a testing ground for your innovation? SAIL and the Amsterdam Marathon present an excellent opportunity to test your ideas. These major events attract millions of visitors and come with sustainability, accessibility, and logistical challenges that need fresh solutions. The In Residence Events program allows you to test your innovation during these […]
News
VU researchers develop research equipment to identify contaminants in water
Water, comprising over 70% of our planet, is the source of all life. The presence of emerging contaminants in our water, including pharmaceuticals, pose serious health and environmental risks, such as DNA damage, reproductive issues, and cancer. New equipment to detect these contaminants developed by VU researchers has been sold to other research groups all over the world. Now the researchers are taking the next step, together with IXA, to expand sales to water companies worldwide as well as other applications such as food and drug discovery research.
News
Tackling learning difficulties in Academic Workplace
The Academic Workplace Rudolf Berlin Center (AW RBC) aims to make a meaningful contribution by supporting young people with learning disabilities through enhanced education and care.
News